Loading company…
Tectonic Therapeutic develops therapeutic proteins and antibodies that target G-Protein Coupled Receptors.
Founded in 2019 and based in Watertown, US, Tectonic Therapeutic develops biologic medicines targeting G-Protein Coupled Receptors. Its GEODe™ platform supports drug discovery, including programs for pulmonary hypertension and hereditary hemorrhagic telangiectasia. In February 2025, it raised USD 185 mn through PIPE funding to support clinical development of TX45 and TX2100 and advance its discovery platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in